Anthera Pharmaceuticals, Inc.
ANTH
ANTH was delisted on the 27th of June, 2018.
43 hedge funds and large institutions have $65.9M invested in Anthera Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 9 closing their positions.
268% more capital invested
Capital invested by funds: $17.9M → $65.9M (+$48M)
113% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 8
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
16% more funds holding
Funds holding: 37 → 43 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less call options, than puts
Call options by funds: $321K | Put options by funds: $392K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$4.07M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$3.51M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$2.64M |
| 4 |
PAI
ProQuest Associates IV
Naples,
Florida
|
+$2.4M |
| 5 |
BC
Broadfin Capital
New York
|
+$2.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$2.67M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$884K |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$395K |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$370K |
| 5 |
SIM
Spark Investment Management
New York
|
-$322K |
ANTH Hedge Fund Activity: Q1 2015 in Review
43 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q1 2015, worth a combined $65.9M — up 268% from $17.9M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new ANTH positions and 9 closed out — a net gain of 6 holders — while 17 added to existing stakes and 8 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $4.07M. The largest seller was Deerfield Management, exiting entirely with an estimated $2.67M sold.
- 43 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q1 2015, up from 37 in Q4 2014.
- Funds reported $65.9M of Anthera Pharmaceuticals, Inc. stock for Q1 2015, up 268% quarter-over-quarter.
- 15 funds opened new Anthera Pharmaceuticals, Inc. positions in Q1 2015 and 9 closed out, a net change of +6 holders.
- The largest Anthera Pharmaceuticals, Inc. buyer in Q1 2015 was Perceptive Advisors, an estimated $4.07M added.
- The largest Anthera Pharmaceuticals, Inc. seller in Q1 2015 was Deerfield Management, an estimated $2.67M sold.
Based on aggregated 13F filings for Q1 2015.